Treatment With ABT-199 (Venetoclax) and Purine Analogues in Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT05506332 · RECRUITING

Trial details

NCT number: NCT05506332
Sponsor: University Hospital, Antwerp
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, in Relapse Acute Myeloid Leukemia Refractory

Start date: 2022-07-15
Primary completion: 2024-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.